News & Updates
Filter by Specialty:
Ritlecitinib, brepocitinib superior to placebo for inducing remission in UC
Ritlecitinib and brepocitinib as induction therapies for ulcerative colitis (UC) appear to be more effective than placebo while having an acceptable short-term safety profile, according to the results of a phase IIb study.
Ritlecitinib, brepocitinib superior to placebo for inducing remission in UC
13 Jan 2023
Regular coffee intake may lower T2D risk in women with gestational diabetes
Women with a history of gestational diabetes mellitus (GDM) may benefit from habitual consumption of caffeinated coffee to prevent progression to type 2 diabetes (T2D) and have a more favourable metabolic profile, suggests a study.
Regular coffee intake may lower T2D risk in women with gestational diabetes
13 Jan 2023
Regdanvimab for COVID-19 effective against Delta variant
The neutralizing antibody regdanvimab appears to be useful in the treatment of mild-to-moderate COVID-19, with a recent study showing that the drug may prevent disease worsening in patients, including those infected with the Delta variant.
Regdanvimab for COVID-19 effective against Delta variant
13 Jan 2023
KRAS G12C inhibitors show promise in metastatic colorectal and pancreatic cancers
The KRASG12C inhibitors, adagrasib and sotorasib, have shown promising antitumour activity in patients with heavily pretreated metastatic colorectal cancer (mCRC) and metastatic pancreatic cancer, respectively.
KRAS G12C inhibitors show promise in metastatic colorectal and pancreatic cancers
13 Jan 2023
IOP-induced ONH strains negatively tied to retinal sensitivity in glaucoma patients
Optic nerve head (ONH) strains under intraocular pressure (IOP) show a negative association with retinal sensitivity in patients with open-angle glaucoma, according to a study. In particular, high-tension glaucoma (HTG) patients with higher ONH strains are more likely to show lower retinal sensitivities.
